ACCESS SOLUTIONS

Donation Programs

Tanner offers pharmaceutical companies a lower-cost alternative to bridge treatment for trial patients until a medicine is commercially available.

HOW IT WORKS

We make giving easier

A growing number of pharmaceutical companies wish to donate their medicines in low- and middle-income countries where patients do not have the insurance or financial means to pay for them. But companies that contemplate such socially driven initiatives may be daunted by supply chain control and quality assurance concerns, inadequate understanding of local healthcare systems, and the requirement to partner with non-governmental organizations (NGOs) and ministries of health.

Tanner got its start by setting up and managing the world’s largest oncology medicine donation program in partnership with The Max Foundation, a global NGO committed to increasing global access to treatment, care and support for people living with cancer. Since then, Tanner has worked with several pharmaceutical companies and NGOs on similar initiatives. At Tanner Pharma, we are passionate about the work we do in the social sector and the opportunity we have to make a positive impact on lives around the world.

Contact Us

FEATURE

Tanner Pharma Stories

Tanner Pharma Group collaborates and partners with pharma companies, physicians, patients and NGOs to provide access to life-saving medicines across the globe. We hope you enjoy the story behind one of our non-profit partnerships.

OUR ACCESS SOLUTIONS

From Early-Access to Compassionate Use, we take a comprehensive approach to access solutions.

  1. Expanded Access Programs

    US FDA regulated pathways that allow provision of investigational new drugs (INDs) to patients with serious diseases or conditions who have exhausted approved therapy and cannot participate in a clinical trial.

  2. Compassionate Use

    The use of a new, unapproved drug to treat a seriously ill patient when no other treatments are available.

  3. Post-trial Supply

    A program to maintain supply of the medicine to patients until it becomes commercially available.

  4. Early Access Programs

    Allow pre-approval access to medicines for certain patients

  5. Donation Programs

    Programs for pharmaceutical companies that are seeking to donate their medicines in low- and middle-income countries where patients do not have the insurance or financial means to pay for them.

  6. Drug Shortages

    A service that sets up the infrastructure to respond to supply chain disruptions that can cause drug shortages and mitigate the impact on patient access to their medicines.

  7. Market Withdrawals

    Providing ways to access a market post-withdrawal where demand from physicians and patients remain, and we can help.

  8. Global Access

    We have the ability to access all products for request internationally – finding access to products in unmet demand of markets of need. We do this through NPP (processed through import).

  9. Clinical Supply Gatekeeper

    We can help you effectively manage inbound requests for comparators and reference listed drugs.

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.